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Abstract
Objective—We evaluated the efficacy of a brief motivational intervention (MI) counseling in 
reducing alcohol consumption among persons living with HIV/AIDS (PLWHA) in Kampala-
Uganda.
Methods—PLWHA attending an outpatient HIV clinic with alcohol disorders identification test-
Consumption component (AUDIT-C) score ≥3 points were randomized to either standardized 
positive prevention counseling alone or in combination with alcohol brief MI counseling. Mean 
change in AUDIT-C scores over 6 months were compared by treatment arm.
RESULTS—The mean (SD) AUDIT-C scores were 6.3(2.3) and 6.8(2.3), for control and MI arms 
(p=0.1) at baseline and change in mean AUDIT-C score was not statistically different between the 
treatment arms over the 6 months follow up time (P=0.8).
CONCLUSION—There was a non-differential reduction in alcohol consumption in both 
intervention and control arms. Standard positive prevention counseling should be provided to all 
PLWHA who use alcohol. Studies with more than one counseling session need to be evaluated.
Clinical trials.gov trial identifier: NCT01802736.
Corresponding author: Dr Bonnie Wandera, Makerere University School of Public Health, Tel: +256712470711, 
bonniewandera@yahoo.com. 
HHS Public Access
Author manuscript
J Int Assoc Provid AIDS Care. Author manuscript; available in PMC 2018 May 01.
Published in final edited form as:
J Int Assoc Provid AIDS Care. 2017 ; 16(3): 276–285. doi:10.1177/2325957416649669.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
INTRODUCTION
By end of 2014, nearly 37 million people were living with HIV/AIDS globally of which 
25.8 million were in the Sub-Saharan Africa (SSA) region1. SSA countries have per capita 
alcohol consumption levels that are well above the global average of 6.2 liters of pure 
alcohol per year2. With the high prevalence of both HIV/AIDS and excessive alcohol 
consumption in SSA, it is not surprising that there is a high prevalence of alcohol use among 
PLWHA3–5.
Alcohol use increases the risk for acquisition and transmission of HIV6,7, while specifically 
in PLWHA, alcohol use is associated with delayed entry and poor retention in care8,9, 
reduced adherence to antiretroviral therapy (ART)10, increased risky sexual behaviors11, 
impaired immunological and virological response to ART12,13. Therefore, interventions to 
reduce alcohol use among PLWHA could lead to improvement in HIV treatment outcomes 
and potential reduction in further HIV transmission risk14.
Hazardous alcohol use, a pattern of drinking that increases the risk of harmful 
consequences15, is traditionally treated with brief interventions (usually lasting less than 30 
minutes a session) over 1 to 6 sessions to prevent development of harmful alcohol problems 
including alcohol dependence16.
Several brief alcohol reduction interventions have been tested in PLWHA, however, most 
were done in high-income settings mainly in North America17,18. Findings from some trials 
show effective reduction in alcohol consumption, while others show no effect19. These 
findings may not be generalizable to SSA, where fewer studies have been done. A study 
conducted in Kenya showed that 6 sessions of cognitive behavioral therapy (CBT) resulted 
in significant reduction in percentage of alcohol drinking days among subjects in the CBT 
arm compared to the controls who received the standard usual care20. Another trial done 
among tuberculosis infected subjects in south Africa, of whom 54% where HIV infected 
showed that the information-motivation-behavioral skills intervention counseling was not 
more effective that an education leaflet given to participants21. With these few studies 
conducted, the effectiveness of brief alcohol reduction interventions among PLWHAs in 
SSA is not yet clearly known hence the need for additional studies among HIV infected 
alcohol drinkers22–24.
Among the different brief alcohol reduction interventions, Motivation intervention(MI) is 
one of the most efficacious interventions for hazardous alcohol use25. MI is a form of 
directive client centered counseling approach that enhances the motivation to reduce alcohol 
use by helping the participants clarify and resolve their ambivalence about reducing alcohol 
use26. MI may be provided as a single session with a view that once subjects get motivated, 
they proceed to mobilize within themselves their own change resources without additional 
training in behavior change skills. The ability to deliver MI in a single session makes it 
particularly attractive in SSA which has a heavy workload in a setting of limited health care 
workers27. We evaluated the efficacy of a single brief Motivation Intervention (MI) 
counseling session on reduction of hazardous alcohol consumption among PLWHA not 
seeking alcohol-use care in Kampala Uganda.
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METHODS
Study design, setting and population
This was a randomized trial (clinical trials.gov trial identifier NCT01802736) among HIV 
infected participants not seeking treatment for alcohol use. The study was conducted at the 
Adult Infectious Diseases Institute clinic (AIDC) located within the Mulago National 
referral and teaching hospital complex in Kampala Uganda. Details of the clinic population 
and services have been published previously5. This clinic has not had any prior alcohol 
intervention trials.
Enrollment procedures
To achieve a representative sample, every 15th patient returning for a clinic appointment was 
initially assessed for eligibility to participate in the screening for alcohol consumption. 
Participants were eligible for alcohol screening if they were; i) aged ≥ 18 years, ii) planning 
to continue receiving care or be followed up at the AIDC for the next 6 months and, iii) 
willing to provided written informed consent. Participants were excluded if they were very 
sick with Karnofsky clinical performance score <50 or if they were pregnant.
All participants fulfilling the initial screening were evaluated for alcohol consumption using 
the 10-item Alcohol Use Disorders Identification Tool (AUDIT) by a trained nurse-
counselor, not involved in provision of routine care, in a private non-treatment/consultation 
room. The sum of the first 3 questions of the AUDIT questionnaire that capture alcohol 
consumption frequency, quantity and binge drinking, referred to as AUDIT-C, were used to 
screen for hazardous alcohol use28,29. The AUDIT-C tool has a minimum score of 0 and 
maximum score of 12 points. Participants with an AUDIT-C score of 3 and above were 
enrolled into the study.
In addition to the AUDIT interview, additional alcohol consumption evaluations were 
conducted on enrolled participants using alcohol Timeline Follow-back (TLFB) method to 
record days on which alcohol consumption occurred or did not occur within 30 days 
preceding the interview. The types and brand of alcohol consumed, on a typical drinking day 
was also collected. Information on socio-demographics, HIV treatment history, and alcohol 
consumption was also collected. Specifically data on participant age, sex, marital status, 
religion, highest educational level, employment status and income in the last month were 
collected. Participants were evaluated for depression using the 10-item Center for 
Epidemiology Studies on Depression tool (CESD-10). HIV clinical data including, HIV/
AIDS clinical stage, ART receipt status, and CD4 cell count were abstracted from clinic 
records. Self-reported adherence to medication in the last one month was assessed in both 
ART and non-ART receiving subjects using a visual analog scale ranging from 0–100 with 0 
representing all prescribed treatment (ART or co-trimoxazole for those not yet on ART) not 
taken while 100% representing no missed medication.
Randomization and treatment allocation
Participants with an AUDIT-C score ≥3 were randomized to one of two study arms 
(standardized positive prevention counseling alone or standardized positive prevention 
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counseling plus MI counseling). The randomization was based on a computer generated 
random numbers using permuted blocks of 6, 8 and 10 for an overall total of 15 blocks and 
assigned to the 2 arms randomly in a 1:1 ratio. Participants were randomized using 
previously prepared, consecutively numbered, opaque, sealed envelopes. Inside the 
envelopes was a written paper marked with the treatment arm assignment. Treatment 
allocation was done by the study nurse who provided assessment interview by opening the 
next sequentially numbered sealed opaque envelope to reveal the participant’s study arm. 
The participant was then taken to the respective counselor to receive their assigned 
counseling.
Study interventions
Both the control and intervention were designed with consultation of a psychologist and 
social scientist and were administered on the same day after the enrollment interview to 
subjects who had scored ≥ 3 points on the AUDIT-C. The goal of the treatments was to 
reduce alcohol use to as low as possible and to abstinence for participants who wished to 
subsequently abstain from it. The treatments were administered by different study personnel 
with two counselors dedicated exclusively to each treatment arm.
The intervention arm received the standardized “positive prevention” information and advice 
and in addition, received a single brief alcohol counseling session lasting between 20–30 
minutes based on MI style. During the counseling sessions, the counselor reflectively 
listened to the participant elaborate their alcohol use, reaffirmed the issues surrounding the 
alcohol use, and inquired about the participants’ plans to reduce alcohol use. The counselor 
strived to elicit, from the participant, the possible benefits and harms of not cutting down on 
their alcohol, what they have done along the way to try and cut down if any, what made them 
fail and what they are willing to do about those previous attempts to cut down. The 
counselor summarized the issues as presented by the participant, recognized and 
commended their efforts in trying to reduce their alcohol use, as well as corrected any 
misinformation that may have arisen. The participant then set a personal goal, of what they 
plan do for the next 6 months in reducing their alcohol use.
The active control arm received only a one on one set of standardized “positive prevention” 
information and advice lasting between 10–30 minutes delivered by a trained counselor. The 
“positive prevention” messages covered the following: how to prevent opportunistic 
infections, nutritional advice, supporting adherence to medications, encouraging HIV 
disclosure to sexual partners, safer sex practices including condom and contraceptive use, 
preventing sexually transmitted infections as well as avoiding alcohol and substance use. 
The counselor informed the participant the risks of alcohol use and encouraged them to 
reduce alcohol intake. After the counseling, participants were provided information on when 
they will be seen again and they proceeded to attend the other routine clinic procedures.
Follow up study assessments
At the follow-up visits, at 3 and 6 months post enrollment, participants’ alcohol use that 
occurred since they were last seen was collected using the same methods as at baseline with 
modification of AUDIT to reflect a shorter inter-visit period of 3 months.
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Implementation, training and support
The treatments were provided by minimum of bachelor’s degree trained counselors and all 
had > 5 years clinical experience in HIV clinical counseling strategies but not alcohol 
counseling experience. Counselors received induction training and individual ongoing 
support. A training workshop specifically on treatment administration as well as receiving a 
treatment manual for the contents and mode of administration of counseling messages were 
done. There was role playing for potential participant presentations specifically for the MI 
arm and guidance how the counselor would proceed. During study implementation, there 
was one refresher training to emphasize adherence to treatment protocols. We carried out no 
formal assessment of treatment adherence and fidelity.
Statistical analysis
We aimed to test the hypothesis that the brief motivational intervention will result in greater 
reductions in AUDIT-C scores compared to the control arm. Results from a prior cross-
sectional study showed the AUDIT-C standard deviation = 2.65. In order to detect the 
minimum difference in mean AUDIT-C score of at least 1 point or more between study arms 
over 6 months and setting the power at 90 %, using a two sided test and an alpha level =0.05, 
and allowing for a 10% loss to follow up, 160 subjects were needed per study arm.
Data were collected on paper forms and double entered in a customized Microsoft access 
database (Microsoft Corp. Redmond WA). Statistical analyses were carried out using SAS V.
9.1.3 (SAS institute, Cary, NC) based on intention to treat principal, and a p-value < 0.05 
was considered statistically significant.
Descriptive characteristics of the study population were summarized as means (Standard 
deviation, SD) and medians (interquartile range, IQR) for continuous variables and as 
percentages for categorical variables. Baseline characteristics were compared by treatment 
arm using chi-square test for categorical outcomes and t-tests or Wilcoxon test for 
continuous outcomes respectively. Baseline descriptive characteristics were compared by 
treatment arm using chi-square test for categorical outcomes and t-tests or Wilcoxon test for 
continuous outcomes respectively.
To assess study participation and attrition, the proportion of participants seen and those not 
seen at follow-up are calculated and reasons for missing are summarized. Because not all 
subjects returned for both follow-up visits, we tested for baseline factors associated with the 
probability of not having both follow-up visits (versus having two follow-up visits) using 
logistic regression methods.
Using known alcohol concentrations of both commercial and locally brewed alcoholic drinks 
taken on a typical drinking day30, we calculated quantity of alcohol in grams (except for the 
communally served and shared drinks because an individual’s approximate volume 
consumed couldn’t be ascertained), consumed on typical day and converted them to United 
States equivalent standard drinks of ethanol by dividing by 14 grams.
The primary outcome, mean AUDIT-C score, was compared using the independent samples 
t-test by treatment arm at each study visit. Furthermore, the mean AUDIT-C score at 3 and 6 
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months within each treatment arm was compared with the mean baseline AUDIT-C using the 
dependent samples t-test. The difference in the AUDIT-C score between 6 months and the 
baseline were calculated for each subject and categorized as a reduction in alcohol use 
frequency and volume if the difference less than 0 or no reduction if the AUDIT-C difference 
was ≥ 0 points.
To assess the intervention effect over time, we used linear mixed effects model with the 
AUDIT-C score as the outcome, treatment arm by follow up time interaction, fixed effect of 
baseline AUDIT-C and follow-up time while the random component consisted of a random 
intercept for each subject and a random slope that allows the correlations between the 
repeated AUDIT-C measurements to vary over the follow-up time.
To examine gender differences in the intervention effects, we constructed separate linear 
mixed effects model in the strata created by gender.
A set of secondary outcomes, namely proportion of participants with full AUDIT score ≥ 8 
points, median number of drinking days in the last one month, average number US 
equivalent standard drinks of alcohol consumed on a typical drinking day were compared 
between the treatment arms at the 3 and 6 months visit using chi-square, Wilcoxon rank 
sum, and student-t independent samples tests.
To examine the robustness of our primary findings to missing data or categorical outcome 
variable, a set of two sensitivity analyses were conducted. The primary linear mixed model 
was rerun after multiple imputation of missing data. Because we had non-monotone 
missingness, we used the Markov Chain Monte Carlo method to create 20 imputed datasets 
that were further analysed as the primary outcome analysis and their results combined using 
the proc MIanalyse function in SAS.
Ethics statement
The study was approved by the scientific review committee of the Infectious Diseases 
Institute, the Makerere University School of Public Health Research and Ethics Committee 
and the Uganda National Council of Science and Technology. The trial was registered on the 
United States clinical trials registry trial identifier NCT01802736. All subjects provided 
individual written informed consent and received no monetary compensation for 
participation.
RESULTS
Descriptive characteristics
Between August 2013 and April 2014, 1,253 subjects were approached, of whom 982 
(78.4 %) fulfilled the initial eligibility criteria and were screened for alcohol use. Of these, 
342 (34.8%) subjects scored 3 or more points on the AUDIT-C test of which 337 accepted 
and were randomized to the two study arms (Figure 1).
The median (interquartile range, [IQR]) age of the enrolled participants was 39 (32–46) 
years, 221 (65.6%) were males, 303 (89.9%) were employed and 258 (76.6%) were 
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receiving ART. Baseline characteristics were similar in the two arms (table 1), except the 
median CD4 cell count which was higher in intervention arm 424(288–567) compared to the 
control arm 363 (264–480) cells/µl, p < 0.001. The mean AUDIT-C score at baseline were 
comparable in the treatment arms, (6.4 SD 2.2 in the control and 6.8 SD 2.3) in the 
intervention arms respectively, p= 0.099).
The mean AUDIT-C score at baseline were comparable in the treatment arms, i.e 6.4 
(standard deviation [SD] 2.2) in the control and 6.8 (SD 2.3) in the intervention arms 
respectively, p= 0.099.
A total of 286/337 (84.9 %%) participants returned for the 3-month visit and 321 (95.3%) 
returned for the 6-month visit (fig. 1). Overall, 304 (90.2%) returned for at least one follow-
up visit while 280 (83.1%) returned for both follow-up visits. There was a statistical trend 
for subjects with baseline full AUDIT scores above 8, not completing both follow up visits, 
(OR= 1.9, 95% CI 0.96–3.75, p=0.06). The odds of not completing both follow up visits 
were 14% higher for every one point increase in baseline AUDIT-C scores. The odds of not 
completing both follow-up visits did not differ by treatment arm, subject characteristics, 
CD4 level or adherence level.
Change in alcohol consumption over time
There was an overall reduction in the mean AUDIT-C score in the 6 months of follow up 
(from 6.4 to 3.4 [p< 0.0001] in the control arm and 6.8 to 3.9 (p= 0.001) in the intervention 
arm).
The decline in both arms was greatest in the first 3 months after the counseling (table 3). The 
mean AUDIT-C score at 3 months was significantly lower in the control arm compared to 
the interventional arm (control group 3.5 [SD 3.0] versus 4.3 [SD 3.0] in the interventional 
group p=0.034) (table 2), however, the mean scores were not different between groups at 6 
months (control group 3.4 [SD 3.0] versus 3.9 [SD 3.0] in the interventional group p=0.141).
There was no significant difference in mean AUDIT-C change over the 6 months follow-up 
time between the intervention and the control arms, mean AUDIT-C difference of the 
differences = −0.07, 95% CI −0.70 – 0.56, p= 0.8266 (table 3).
The proportion of participants with mean AUDIT-C scores ≥ 3 was significantly lower in the 
control group compared to the interventional arm at 3 months (58.5% in control group 
versus 71.5% in interventional group p=0.019) and at 6 months (57.2% in control group 
versus 70.2% in interventional group p=0.024).
Overall, 354/610 (58%) of the person-visits had reduction in AUDIT-C scores, with no 
differential AUDIT-C reduction by arm, that is 180/304 (59.2%) persons-visits in the 
intervention arm and 174/306(56.9%) in the control arm (p=0.56). The majority, 
22/354(62.7%) of the reductions occurred in the first 3 months, with the remaining 
132/354(37.3%) occurring between the 3 and 6 months visit. There was no statistically 
significant difference in the proportion of participants who had a reduction in AUDIT-C 
score between the baseline and month six visit in intervention arm 128/157(81.5%) versus 
control 121/157 (77.1%) arm, (p= 0.3296).
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Gender stratified mixed effects model showed that mean difference in AUDIT-C change over 
time was not different by treatment arm among males (0.38, 95%CI −0.41–1.17, p= 0.3493) 
while among females, the MI arm had greater AUDIT-C reductions compared to control arm 
(−1.10, 95% CI −2.19 – −0.02, p=0.0457).
Although the median drinking days were not different between arms at baseline, (6.0 in 
control versus 7.0 in intervention group), the drinking days were significantly lower in the 
control group compared to the interventional group (3.0 in control versus 4.0 in intervention 
group). However, no difference was observed in median drinking days between the two arms 
at 6 months of follow up. A similar trend was observed in the mean number of drinks 
consumed (table 2).
DISCUSSION
Identifying an efficacious single session brief alcohol intervention would greatly reduce the 
consequences of hazardous alcohol consumption among PLWHA in SSA. Brief alcohol 
interventions, especially those limited to a single session that can be integrated into routine 
care, are advantageous for resource-limited settings31. In this trial we observed significant 
reductions in alcohol consumption after a single brief counseling session among HIV 
infected men and women consuming alcohol at hazardous levels and not seeking treatment 
for alcohol use in Kampala, Uganda. The greatest reductions in alcohol use were in the first 
3 months after the intervention. There were minimal reductions observed between the 3 and 
6 months interval. The proportion of participants with reduction in AUDIT-C scores was 
higher but the difference was not statistically significant in the intervention arm compared to 
the active control arm. Similarly there was no statistically significant difference in mean 
change in AUDIT-C scores 6 months following the intervention and control treatment 
counseling. The trial shows that MI counseling did not result in greater reductions in alcohol 
consumption over and above the standard of care positive prevention counseling among HIV 
infected persons with hazardous alcohol use.
Our study is one of the few studies in SSA that has attempted to reduce alcohol consumption 
among PLWHA not seeking care for their alcohol use and increases our understanding of 
alcohol use interventions in this setting. Moreover our use of random allocation of treatment 
and a single MI session is in line with the mesa grande recommendations25.
Despite evidence from systematic reviews demonstrating support for the use of brief alcohol 
interventions and motivational interviewing in primary care settings to reduce both alcohol 
use and related behaviors32,33 we did not observe similar results among PLWHA in Uganda. 
The difference in the findings is that the studies included in the reviews used participants 
whose HIV status was either unknown, or HIV un-infected and were from settings of low 
HIV prevalence while this study was exclusively among HIV positive participants enrolled 
in clinical care. In the few trials conducted among PLWHA, similar findings of no effect of 
the intervention were observed by Samet et al in 151 PLWHA in Boston,34 and two other 
trials, one by Gilbert et al using the “Video doctor” and by Parsons et al using cognitive 
behavioral and skills training demonstrated no difference in alcohol consumption in the 
interventional group compared to standard of care after 6 months19,35.
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In fact, a synthesis of interventions among only PLWHA by Brown and colleagues 
concludes that the reviewed studies provided mixed results on reduction in both alcohol 
frequency and quantity between the intervention and comparison conditions with six of the 
studies demonstrating significant reductions in alcohol frequency and quantity between the 
intervention and comparison conditions and the other six showing no significant 
interventions effects.36 Among the studies with efficacious intervention effects, is one study 
done in a typical SSA large outpatient HIV clinic in western Kenya, recruited HIV infected 
hazardous/binge drinkers, using 6 sessions of cognitive behavioral therapy, delivered by 
para-professionals resulted in greater alcohol reductions in the intervention compared to a 
standard of care control20. Another trial by Velasquez et al, among HIV infected men who 
have sex with men, participants randomized to 4 session of motivational interview 
counseling significantly reduced their number of drinks as well as heavy drinking in the last 
30 days compared to the controls who received educational material only37. The difference 
between this trial and our trial is that the intervention was provided in more than one session 
and effects were assessed after a short time interval of 30 days. Indeed, our trial shows that 
the reductions in alcohol consumption are realized within the first few months closest to the 
intervention(s)37. A more recent trial among only HIV infected women showed that 2 
sessions of brief intervention resulted in a 58% reduction in the 90-days alcohol 
consumption frequency over 12 months in the intervention arm38.
The marked but non differential reductions in alcohol consumption as measured by AUDIT-
C suggests that both the intervention and control had equally “partially effective 
components”39 because our “active” control arm also received one on one counseling 
messages unlike other studies that use patient leaflets in the control arm.
Prior research has shown that participation and answering alcohol assessment questions may 
lead in reduced reporting of drinking behavior, mainly due to self-reflection and/or 
assessment reactivity to alcohol related questions40. These effects therefore may have 
distorted the measured intervention effects and could account for the lack of effect noted in 
our study. However, it is not possible to determine whether these effects occurred and 
whether any such effects were differential by treatment arm.
We observed differential intervention effects by gender, with a statistically significant effect 
of MI only among female participants. This suggests a possible gender interaction effects, 
although our study was not powered to test the significance of this interaction. It is possible 
that the men were not satisfied with the one on one counseling style as has been previously 
proposed in a study conducted in south Africa41. Additional studies are required to confirm 
this apparent beneficial effect of MI among only women.
These results need to be interpreted in the context of the following limitations. We used self-
reported measures of alcohol consumption which may be prone to recall and social 
desirability response biases. The best way to validate the self-report would be to use alcohol 
biomarkers; however this was not feasible at the time the study commenced and we believe 
that our use of the timeline follow-back method aided in alcohol use recall42. Although we 
conducted baseline alcohol assessment interviews prior to randomization, we are not able to 
ascertain whether there was any differential bias in reporting alcohol use by study arm 
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during the follow-up period. Biomarkers have revealed differing drinking results as 
compared to self-report (Hahn et al in press), therefore future studies in this setting should 
consider their use.
Although we did not provide an objective assessment to fidelity of the intervention, we 
provided pre-implementation training, study treatment manuals and continuous 
implementation support to ensure that the interventions were provided as per the protocol. 
The duration of follow-up may have been short to comprehensively ascertain the effects of 
the counseling programs and therefore we may have recorded only the short term efficacy of 
the counseling programs. We did not expect a longer effect with a single counseling. We 
observed most of the reductions in the first 3 months, probably an indicator that a single 
counseling session effects may not be maintained over a longer duration. Therefore, future 
studies may need to consider addition of booster counseling sessions.
Our findings are from a single HIV clinic thus may not be generalizable; however, this clinic 
has a patient population that is similar to a typical patient population of PLHWA in SSA43.
Based our findings and from literature on interventions for alcohol use among PLWHA, a 
single session of MI may not result in significantly greater reduction in alcohol use 
frequency and quantity over six months as compared to general positive prevention 
counseling in HIV clinics. Therefore, strengthening and standardizing the current positive 
prevention messages to always include alcohol reduction information to is a feasible and 
should be taken up in current HIV clinical practice. These counseling messages are easily 
administered by trained routine care provider (rather than a specialist counselor) and are 
brief allowing for incorporation into routine clinical care.
It is possible that more interventional effects may be demonstrated with repeated MI 
sessions in PLWHA with hazardous alcohol use more so among female subjects. Therefore, 
a larger trial, designed to address the apparent gender interaction, providing additional 
counseling sessions and longer follow-up evaluations possibly supported with innovative 
interactive telephony and technology support and objectively assess alcohol consumption 
using biomarkers is needed. In addition, identification of determinants and mediators of 
treatment response and the best measures of motivation to reduce alcohol use and how these 
measurements should be assessed in subsequent studies and practice on the treatment of 
alcohol use among PLWHA in SSA
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Figure 1. 
Trial profile of PLWHA enrolled in the Alcohol intervention trial at the Infectious Diseases 
institute, Kampala Uganda.
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Table 1
Baseline Characteristics of PLWHA by treatment allocation group, enrolled in the ASK trial, Kampala Uganda
Characteristic All subjects
N (%)
337
Control arm
N (%)
170(50.5)
Intervention arm
N (%)
167(49.5)
Median Age (years, IQR) 39(32–46) 40(32–45) 39(31–46)
Gender
Male 221(65.6) 113(66.5) 108(64.7)
Female 116(34.4) 57(33.5) 59(35.3)
Education Level
Primary or less 167(49.6) 74(43.5) 73(55.7)
Secondary level 129(38.3) 73(42.9) 56(33.5)
Tertiary / diploma 41(12.2) 23(13.5) 18(10.8)
Religion ~
Roman Catholic 152(45.4) 65(38.5) 87(52.4)
Anglican 152(45.4) 85(50.3) 67(40.4)
others: Pentecostal/Muslim 31(9.2) 19(11.2) 12(7.2)
Income in last Month
< 20 USD 55(16.3) 27(15.9) 28(16.8)
20–400 USD 254(75.4) 130(76.5) 124(74.3)
> 400 USD 24(7.1) 11(6.5) 13(7.8)
Declined 4(1.2) 2(1.2) 2(1.2)
Paid employment
Yes 303(90.2) 154(91.1) 149(89.2)
No1 33(9.8) 15(8.9) 18(10.8)
Marital status
Single/Never Married 36(10.8) 14(8.4) 22(13.2)
Married/Cohabiting 185(55.4) 90(53.9) 95(56.9)
Single/Separated//Widowed 113(33.8) 63(37.7) 50(29.9)
HIV/AIDS Clinical Stage
I & II 145(44.3) 71(42.8) 74(46.0)
III & IV 182(55.7) 95(57.2) 87(54.0)
CD4 Cell count Median (IQR) cells/mm3 382(276–509) 363(264–480) 424(288–567)
Receiving ART
Yes 258(76.6) 134(78.8) 124(74.3)
No 79(23.4) 36(21.2) 43(25.8)
Adherence to Medication&
< 95% 115(34.2) 59(34.7) 56(33.5)
≥ 95% 222(65.9) 111(65.3) 111(66.5)
CESD-10 score
J Int Assoc Provid AIDS Care. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Wandera et al. Page 16
Characteristic All subjects
N (%)
337
Control arm
N (%)
170(50.5)
Intervention arm
N (%)
167(49.5)
< 10 points 247(73.3) 125(73.5) 122(73.1)
≥ 10 points 90(26.7) 45(26.5) 45(27.0)
Baseline AUDIT-C score
Mean (standard deviation)
6.6(2.3) 6.3(2.3) 6.8(2.3)
Median (IQR) 6.0 (5.0–8.0) 6.0(5.0–8.0) 6.0(5.0–8.0)
Mean (standard deviation) baseline full
AUDIT Score
11.3(6.2) 11.1(6.2) 11.4(6.2)
Full AUDIT score category
< 8 106(31.4) 56(32.9) 50(29.9)
≥ 8 231(68.5) 114(67.1) 117(70.1)
Mean (standard deviation) Number of
drinking days in last one month
9.1(8.9) 8.5(8.4) 9.8(9.3)
Median (IQR) Number of US standard
drinks taken on typical drinking day
4.8(4.0 – 7.0) 4.8(4.2–7.0) 4.8(4.0–6.4)
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Table 3
Results of Linear mixed model of Alcohol use disorders identification test-Consumption (AUDIT-C) scores by 
arm and over time in Kampala Uganda.
Outcome classification Mean
AUDIT-C
change
95% CI p-value
Intervention effect of
MI (versus SPP) at 6
months
Complete
case
analysis
−0.07 −0.70 – 0.56 0.8266
Intervention effect of
MI (versus SPP) at 6
months
Multiple
imputation
0.01 −0.32–0.34 0.9440
Intervention effect of
MI (versus SPP) at 6
months
Males only
complete
cases
0.38 −0.41–1.17 0.3493
Intervention effect of
MI (versus SPP) at 6
months
Females
only
complete
case
analysis
−1.10 −2.19 – −0.02 0.0457
All models are linear mixed effects adjusting for follow up visit, and baseline AUDIT-C score, random intercept and random slope for follow-up 
visit.
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